#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary arterial hypertension Fibrous dysplasia of bone Laryngeal squamous cell carcinoma Acute myeloid leukaemia recurrent Dent's disease Endometrial adenocarcinoma Extra-osseous Ewing's sarcoma recurrent Leukaemia Alveolar proteinosis Ureteric cancer B-cell small lymphocytic lymphoma refractory Alexander disease VEXAS syndrome Infantile apnoea Partial lipodystrophy More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Treatment Rhabdomyosarcoma – Trials in Disease Angelman’s syndrome – Basic Information Andersen-Tawil syndrome – Life with Disease Amyotrophic lateral sclerosis – Diagnostics Mucous membrane pemphigoid – Basic Information Leukoencephalopathy – Trials in Disease Progressive multifocal leukoencephalopathy Glycogen storage disease type II – Life with Disease Activated PI3 kinase delta syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Baloxavir Marboxil Betahistine Dihydrochloride TRIMIPRAMINE MALEATE Methylprednisolone Aceponate Epinephrine Hydrochloride Ly4100511 Caspofungin FRUQUINTINIB LUMC-BOB1-B7-TCR.1 Bi 1291583 Mps-215 Sotagliflozin Cefoxitin Sodium Tinzaparin Human Serum Albumin Nebivolol Canagliflozin Omx-0407 Gsk4004280 Vidofludimus Calcium More therapies…

    Learn about Your Condition

    Adenomyosis Myotonic dystrophy Leukocyte adhesion deficiency Bacterial vaginosis Pyelonephritis acute Rectal adenocarcinoma Aicardi-Goutieres syndrome Carotid artery occlusion Systemic scleroderma Colorectal adenocarcinoma Tuberculosis Left ventricular dysfunction Palpitations Hypocalcaemia C3 glomerulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Velocity Clinical Research Luebeck GmbH

Velocity Clinical Research Luebeck GmbH

Dtepaucsoykfjgzs 4kplnc Axewaqwcblza Lwbjofij 0nvjiw Gumioit

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Austria Bulgaria Czechia Germany Greece Italy +2

  • Study of tasimelteon compared to placebo for treating insomnia in children

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tasimelteon
    Germany Poland

  • Efficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial

    Recruiting

    4 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • LUNSEKIMIG
    Belgium Denmark Estonia Finland France Germany +7

  • Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Bulgaria Czechia France Germany Greece Hungary +3

  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Indacaterol Acetate
    • Salbutamol
    • Glycopyrronium Bromide
    France Germany Hungary Poland Romania Slovakia +1

  • GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents

    Recruiting

    3 1
    Bulgaria Croatia Czechia Germany Greece Hungary +4

  • Comparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate
    • Beclometasone Dipropionate Anhydrous
    • Glycopyrronium Bromide
    Bulgaria Czechia Germany Hungary Latvia Poland +2

  • A study of brenipatide compared to placebo for the treatment of adults with alcohol use disorder

    Recruiting

    3 1
    Investigated Diseases:
    • Alcohol use disorder
    Investigated Drugs:
    • LY3537031
    Belgium Germany

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A Study to Test How Well PKN605 Works and How Safe It Is in Patients with Atrial Fibrillation

    Recruiting

    2 1
    Investigated Diseases:
    • Atrial fibrillation
    Germany The Netherlands
1 2 3 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!